Xcout IntelSign inSubscribe

Evolutia Inc. competitors & alternatives

BiotechnologyUnited States

The 12 closest competitors and alternatives to Evolutia Inc. among biotechnology companies — ranked by similarity to what Evolutia Inc. actually does, not by market-cap band.

12Competitors listed

Subscribe to see Evolutia Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Evolutia Inc.

Evolutia Inc. provides custom biomanufacturing solutions, including engineered strains, custom enzymes, and scalable production processes for partners in industries such as food and ingredients, agriculture, pharma, and industrial biomanufacturing. Operating in partnership with Mycofeast, the company bridges the gap between lab-scale discovery and commercial-scale manufacturing.

Evolutia Inc. at a glance

Evolutia Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $250,000 in October 2025. Xcout tracks 5 named people at Evolutia Inc., including Chris Thilburg (President).

Evolutia Inc. leadership

  • Chris ThilburgPresident
  • Chris DavisManaging Director
  • Jason LewisManaging Director
  • Vesna MitchellSenior Director, Genetic Engineering
  • Chris ThilburgExecutive Officer

Evolutia Inc. funding rounds

Every round on record:

DateRoundAmountInvestors
SEC Form D filing$250,000—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Evolutia Inc. competitors

Ranked by semantic similarity — how close each company is to Evolutia Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Anthem Biosciences LimitedANTHEM · BiotechBengaluru, India
61% matchPublic

Biotech

Anthem Biosciences Ltd. operates as a technology-driven organization specializing in contract research, development, and manufacturing (CRDMO). The company's activities are organized into two primary divisions: CRDMO services and the production of Specialty Ingredients. Through its CRDMO segment, Anthem Biosciences offers comprehensive, full-lifecycle support for both novel chemical and biological entities. This support spans the entire development pipeline, from initial target identification and concept generation, through preclinical evaluation, the creation of development batches for all three phases of clinical trials, and ultimately, commercial-scale manufacturing. Their expertise covers a wide array of advanced therapeutic areas, including RNA-based therapies, antibody-drug conjugates, peptides, oligonucleotides, lipids, biologics, and biotherapeutics. They also employ specialized processes such as fermentation, biosynthesis, biotransformation, and flow chemistry. In its Specialty Ingredients division, Anthem Biosciences manufactures and supplies intricate, fermentation-derived active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2. The company's portfolio also encompasses microbial and mammalian biosimilars, a diverse range of probiotics (such as various species of bacillus, lactobacillus, bifidobacterium, streptococcus, and saccharomyces boulardii), and enzymes. Additionally, they produce key peptides like semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide, alongside nutritional actives, vitamin analogues, and other APIs. The company was established in Bengaluru, India, in 2006.

Market cap$5.3B
Employees2,062
Anthem Biosciences Limited competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Evolutia Inc. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Evolutia Inc.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →